P2Y12 receptor specific versus non-P2Y12 receptor specific platelet function testing for prediction of pharmacodynamic and clinical outcomes in patients on dual antiplatelet therapy

被引：0
|
作者：
Amann, M. [1 ]
Valina, C. [1 ]
Stratz, C. [1 ]
Boemicke, T. [1 ]
Kleiner, P. [1 ]
Trenk, D. [1 ]
Neumann, F. -J. [1 ]
Hochholzer, W. [1 ]
机构：
[1] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5605
引用
收藏
页码：1163 / 1163
页数：1
相关论文
共 50 条
  • [31] AZD6140.: Antiplatelet therapy, P2Y12 (P2T) receptor antagonist
    Owen, R. T.
    Serradell, N.
    Bolos, J.
    DRUGS OF THE FUTURE, 2007, 32 (10) : 845 - 853
  • [32] Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin
    Cattaneo, M.
    Lecchi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) : 577 - 582
  • [33] Pharmacogenetics of P2Y12 receptor inhibitors
    Thomas, Cameron D. D.
    Williams, Alexis K. K.
    Lee, Craig R. R.
    Cavallari, Larisa H. H.
    PHARMACOTHERAPY, 2023, 43 (02): : 158 - 175
  • [34] Role of P2Y12 Receptor in Thrombosis
    Zhang, Yaqi
    Zhang, Si
    Ding, Zhongren
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 307 - 324
  • [35] Responsiveness to P2Y12 receptor inhibitors
    Esposito, Giovanni
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S31 - S37
  • [36] The future of P2Y12 receptor antagonists
    Thomas, Mark R.
    Storey, Robert F.
    PLATELETS, 2015, 26 (05) : 392 - 398
  • [37] Platelet function assays that assess response to P2Y12 antagonists vary widely in their sensitivities to low levels of P2Y12 receptor blockade
    Judge, H. M.
    Buckland, R. J.
    Sugidachi, A.
    Jakubowski, J. A.
    Storey, R. F.
    EUROPEAN HEART JOURNAL, 2008, 29 : 835 - 835
  • [38] Pharmacodynamic interplay of the P2Y1, P2Y12, and TxA2 pathways in platelets: The potential of triple antiplatelet therapy with P2Y1 receptor antagonism
    Oestreich, Julie H.
    Ferraris, Suellen P.
    Steinhubl, Steven R.
    Akers, Wendell S.
    THROMBOSIS RESEARCH, 2013, 131 (02) : E64 - E70
  • [39] Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
    Wilson, William
    Gurvitch, Ronen
    Ajani, Andrew E.
    CARDIOVASCULAR THERAPEUTICS, 2009, 27 (03) : 194 - 198
  • [40] The influence of variation in the P2Y12 receptor gene on the magnitude of in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, H. J.
    van Werkum, J. W.
    Rudez, G.
    Leebeek, F. W. G.
    Kruit, A.
    Hackeng, C. M.
    ten Berg, J. M.
    de Maat, M. P. M.
    Ruven, H. J. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 587 - 588
12345